Carlsmed files federal patent infringement lawsuit against DeGen Medical
Resolved · regulation · Occurred · Assessed · 1 sources
This assessment is dated 2026-09-16. Check what remains unresolved below before relying on it.
Which companies' revenue or costs change?
Patent infringement injunctive relief threats protect proprietary surgical AI planning software, shielding Carlsmed implant pricing power and commercial market share.
| Question | What the evidence establishes |
|---|---|
| What was reported? | Reported factCarlsmed, Inc. filed a patent infringement complaint against DeGen Medical, Inc. in the U.S. District Court for the District of South Carolina. |
| What else was confirmed? | Reported factThe litigation asserts infringement of eight patents covering AI-enabled personalized spine surgery implants, methods, and surgical systems. |
| Does the valuation support acting? | UnknownNo stored valuation assumptions for CARL yet — this is the next research task. |
| What would change the assessment? | UnknownDistrict Court preliminary injunction ruling — Track docket entries on Carlsmed motion for preliminary injunctive relief in South Carolina District Court. |
What would this event cost your holdings?
Apply your own hypothetical returns to current holding values. The calculator does not infer security effects from this event.
Test this event against my holdingsReported facts
- · Carlsmed, Inc. filed a patent infringement complaint against DeGen Medical, Inc. in the U.S. District Court for the District of South Carolina.
- · The litigation asserts infringement of eight patents covering AI-enabled personalized spine surgery implants, methods, and surgical systems.
- · Carlsmed is seeking preliminary and permanent injunctive relief as well as monetary damages.
Public research record
Research framework · page evidenceCompleted event assessment
patent enforcement protecting proprietary AI surgical planning implant pricing
| Type | Claim | Scope |
|---|---|---|
| Assumption | Carlsmed, Inc. filed a patent infringement complaint against DeGen Medical, Inc. in the U.S. District Court for the District of South Carolina. | 2026-09-16 |
| Interpretation | patent enforcement protecting proprietary AI surgical planning implant pricing | CARL |
Countercase, invalidators, and sources
The court grants a preliminary injunction restricting DeGen competing implant lines, reinforcing Carlsmed market exclusivity in AI spine workflows.
- · District Court preliminary injunction ruling — Track docket entries on Carlsmed motion for preliminary injunctive relief in South Carolina District Court.
- Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical · 2026-09-15
What remains unresolved
- Base path
- Litigation enters discovery with patent claim construction hearings scheduled over the next six to twelve months.
- Adverse path
- Patent claims face validity challenges at the USPTO Patent Trial and Appeal Board, creating legal expense overhead without rapid injunctive remedies.
- Supportive path
- The court grants a preliminary injunction restricting DeGen competing implant lines, reinforcing Carlsmed market exclusivity in AI spine workflows.
- · District Court preliminary injunction ruling — Track docket entries on Carlsmed motion for preliminary injunctive relief in South Carolina District Court.next month
Evidence
- Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical2026-09-15
“Carlsmed, Inc. filed a patent infringement lawsuit against DeGen Medical, Inc. in the U.S. District Court for the District of South Carolina, alleging infringement of eight patents related to AI-enabled personalized spine surgery implants.”
Supports: Carlsmed filed suit against DeGen Medical in US District Court of SC over eight AI personalized spine surgery patents.